Press ContactPriscille Rivière : 01 44 23 60 97
Marine Leroy : 01 44 23 60 73 rf.mresni@esserp
Prof André Syrota, Inserm Chairman and CEO
Researchers, engineers, technicians and administrative staff have all helped make Inserm a universally recognised biomedical research organisation.
Inserm has overcome some major scientific challenges to be at the cutting edge of health research and, since it was founded, has never stopped reaffirming its priorities and goals.
50 years of scientific excellence – The institute has been involved in some important medical advances (cancer treatments, gene therapy, new imaging technologies, discovery of HIV). In the past thirty years, two of its researchers have received the Nobel Prize in Physiology or Medicine. The fact that Inserm has become a producer and disseminator of important scientific work and an expert on health issues is beyond dispute.
50 years of dialogue with society – Keen to make science accessible to a large section of the population, the institute has continuously sought to diversify its awareness-raising activities. Its aim is to familiarise non-specialists with the research sector and the issues it currently faces. In this spirit of openness, Inserm has spent the past ten years working to bring patient associations and researchers together.
50 years of international fame – Over the years, the institute has become firmly established in France and developed its international reputation. It is the top European biomedical research organisation. Inserm has a long tradition of national, European and international cooperation, which has resulted in an increasing number of joint publications.
Highlights marking 50 years of Inserm
To mark its 50th anniversary, Inserm has decided to deliver its key messages at around a hundred events which will take place all over France and involve all its staff, partners and supervisory bodies throughout the year.
To mark its 50th anniversary
Please contact the Inserm press office for any further information, interviews, contact details, illustrations etc. at: rf.mresni@esserp
"A new impetus for health biology research." This is the ambition of Inserm’s Contract of Objectives, Means and Performance signed on Friday, February 4, 2022..
Pour faire avancer plus rapidement la recherche dans le domaine de l’antibiorésistance, des chercheurs de l’Inserm et d’Université Paris Cité lancent un grand programme de recherche participative pour trouver....